- Browse by Subject
Browsing by Subject "hot flashes"
Now showing 1 - 2 of 2
Results Per Page
Sort Options
Item ROLE OF SWEAT GLAND PHYSIOLOGY IN OBJECTIVE GALVANIC SKIN RE-SPONSE MEASUREMENT(Office of the Vice Chancellor for Research, 2012-04-13) Igega, Christele M.; Schild, John; Teach, Heather; Carpenter, Janet S.For the purpose of studying sweat in response to hot flashes, a type of thermal sweating, the process of extensive literature review performed in this particular project focused primarily on the eccrine sweat glands. Of the three categories of sweat glands, eccrine sweat glands account for the ma-jority of the sweat glands on the human body, existing over almost the en-tire body surface, and contributing to thermal sweating. Thermal sweating occurs as a means for the human body to regulate temperature (Johnson 1996). There are approximately 1.6 to 5 million eccrine sweat glands dis-tributed over the surface of the human body. Sweat gland density varies across different regions of the body, with the highest density on the palms of hands and soles of feet, while the lowest sweat gland density of 64 sweat glands per square centimeter is found on the back (Wilke et al., 2007). Wa-ter comprises approximately 99% of eccrine sweat, with the remaining com-pounds consisting mostly of varying amounts of sodium, potassium, calcium, and magnesium (Groscurth, 2002). The Galvanic Skin Response is an objec-tive measure of skin conductance that has been linked with the peripheral sweat rate (Carpenter et al., 2005). Importance has been put upon the po-tential clinical significance of using the Galvanic Skin Response to objectively enumerate the influence and effectiveness of interventions for health related issues in which sweating is a substantial symptom (Tataryn et al., 1981). One of the objectives of this research is to determine the effect that various sweat gland physiological factors, such as density, ionic composition, and sweat rate, may have on the accuracy of different Galvanic Skin Response measurement techniques and devices. 1Center for Enhancing Quality of Life, Indiana University School of Nursing, IUPUI, Indian-apolis, IN 46202Item Vitamin D levels and menopause-related symptoms.(Wolters Kluwer Health, 2014-11) LeBlanc, Erin S.; Desai, Manisha; Perrin, Nancy; Wactawski-Wende, Jean; Manson, JoAnn E.; Cauley, Jane A.; Michael, Yvonne L.; Tang, Jean; Womack, Catherine; Song, Yiqing; Johnson, Karen C.; O’Sullivan, Mary J.; Woods, Nancy; Stefanick, Marcia L.; Department of Epidemiology, Richard M. Fairbanks School of Public HealthObjective: To determine whether vitamin D levels are associated with menopause-related symptoms in older women. Methods: A randomly selected subset of 1,407 women, among 26,104 potentially eligible participants of the Women’s Health Initiative Calcium and Vitamin D (CaD) trial of postmenopausal women aged 51-80 years, had 25-hydroxyvitamin D [25(OH)D] levels measured at the CaD trial baseline visit. Information about menopause-related symptoms at baseline was obtained by questionnaire and included overall number of symptoms and composite measures of sleep disturbance, emotional well-being, and energy/fatigue, as well as individual symptoms. After exclusions for missing data, 530 women [mean age 66.2 years (SD 6.8)] were included in these analyses. Results: There were borderline significant associations between 25(OH)D levels and total number of menopausal symptoms (p values ranging from 0.05 to 0.06 for fully adjusted models); however, the effect was clinically insignificant and disappeared with correction for multiple testing. There were no associations between 25(OH)D levels and composite measures of sleep disturbance, emotional well-being, or energy/fatigue (p’s > 0.10 for fully adjusted models). Conclusions: There was no evidence of a clinically important association between serum 25(OH)D levels and menopause-related symptoms in postmenopausal women.